...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Our own BKC on the webcast

Agreed. Great question BKC, horribly unprepared answer by DM. The company highlighted this LDL-C issue back in November 2019.....DM should not have been blindsided by that question.

I typed in questions that didn't get read:

1) Will there be any renal function endpoints in BETonMACE2?

2) Will the 100 patient COVID-19 trial be all apabetalone treated, or will some of these 100 be standard of care?

BDAZ

Share
New Message
Please login to post a reply